Cargando…
Feasibility study on collecting patient‐reported outcomes from breast cancer patients using the LINE‐ePRO system
Due to the increasing complexity of cancer treatment, ensuring safety and maintaining the quality of life during treatment are important issues. Patient‐reported outcomes (PROs) in oncology are essential for assessing patient symptoms. A feasibility study was undertaken on breast cancer patients by...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128183/ https://www.ncbi.nlm.nih.gov/pubmed/35279907 http://dx.doi.org/10.1111/cas.15329 |
_version_ | 1784712510376509440 |
---|---|
author | Hayashida, Tetsu Nagayama, Aiko Seki, Tomoko Takahashi, Maiko Matsumoto, Akiko Kubota, Anna Jinno, Hiromitsu Miyata, Hiroaki Kitagawa, Yuko |
author_facet | Hayashida, Tetsu Nagayama, Aiko Seki, Tomoko Takahashi, Maiko Matsumoto, Akiko Kubota, Anna Jinno, Hiromitsu Miyata, Hiroaki Kitagawa, Yuko |
author_sort | Hayashida, Tetsu |
collection | PubMed |
description | Due to the increasing complexity of cancer treatment, ensuring safety and maintaining the quality of life during treatment are important issues. Patient‐reported outcomes (PROs) in oncology are essential for assessing patient symptoms. A feasibility study was undertaken on breast cancer patients by building a PRO data collection system based on LINE, one of the most popular social network service applications in Japan. In this study, one or more predefined PRO questions for each breast cancer patient's clinical situation were sent to the patient’s LINE application daily. The patient selected a predefined answer by tapping the screen, but no free‐text answers were allowed. Seventy‐three patients were enrolled. The median observation period was 435 days (84‐656 days), and the total number of PROs collected was 16,417, with a mean of 224.9 reports per patient. Patients on adjuvant endocrine therapy were notified of 2.5 questions per week, and the median number of responses per week and response rate were 2.387 (1.687‐11.627) and 95.5%, respectively. Analyzing the results by age group, the number of responses from those aged 60 and above was equal to or higher than that of the younger age group. It was also possible to track each patient’s PROs accurately. These results suggested that the design of the system, based on an application used daily, instead of using specifically prepared applications for collecting electronic PROs, was the reason for the favorable acceptance from patients and the satisfactory response rate from all age groups, including the elderly. |
format | Online Article Text |
id | pubmed-9128183 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91281832022-05-25 Feasibility study on collecting patient‐reported outcomes from breast cancer patients using the LINE‐ePRO system Hayashida, Tetsu Nagayama, Aiko Seki, Tomoko Takahashi, Maiko Matsumoto, Akiko Kubota, Anna Jinno, Hiromitsu Miyata, Hiroaki Kitagawa, Yuko Cancer Sci ORIGINAL ARTICLES Due to the increasing complexity of cancer treatment, ensuring safety and maintaining the quality of life during treatment are important issues. Patient‐reported outcomes (PROs) in oncology are essential for assessing patient symptoms. A feasibility study was undertaken on breast cancer patients by building a PRO data collection system based on LINE, one of the most popular social network service applications in Japan. In this study, one or more predefined PRO questions for each breast cancer patient's clinical situation were sent to the patient’s LINE application daily. The patient selected a predefined answer by tapping the screen, but no free‐text answers were allowed. Seventy‐three patients were enrolled. The median observation period was 435 days (84‐656 days), and the total number of PROs collected was 16,417, with a mean of 224.9 reports per patient. Patients on adjuvant endocrine therapy were notified of 2.5 questions per week, and the median number of responses per week and response rate were 2.387 (1.687‐11.627) and 95.5%, respectively. Analyzing the results by age group, the number of responses from those aged 60 and above was equal to or higher than that of the younger age group. It was also possible to track each patient’s PROs accurately. These results suggested that the design of the system, based on an application used daily, instead of using specifically prepared applications for collecting electronic PROs, was the reason for the favorable acceptance from patients and the satisfactory response rate from all age groups, including the elderly. John Wiley and Sons Inc. 2022-03-26 2022-05 /pmc/articles/PMC9128183/ /pubmed/35279907 http://dx.doi.org/10.1111/cas.15329 Text en © 2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | ORIGINAL ARTICLES Hayashida, Tetsu Nagayama, Aiko Seki, Tomoko Takahashi, Maiko Matsumoto, Akiko Kubota, Anna Jinno, Hiromitsu Miyata, Hiroaki Kitagawa, Yuko Feasibility study on collecting patient‐reported outcomes from breast cancer patients using the LINE‐ePRO system |
title | Feasibility study on collecting patient‐reported outcomes from breast cancer patients using the LINE‐ePRO system |
title_full | Feasibility study on collecting patient‐reported outcomes from breast cancer patients using the LINE‐ePRO system |
title_fullStr | Feasibility study on collecting patient‐reported outcomes from breast cancer patients using the LINE‐ePRO system |
title_full_unstemmed | Feasibility study on collecting patient‐reported outcomes from breast cancer patients using the LINE‐ePRO system |
title_short | Feasibility study on collecting patient‐reported outcomes from breast cancer patients using the LINE‐ePRO system |
title_sort | feasibility study on collecting patient‐reported outcomes from breast cancer patients using the line‐epro system |
topic | ORIGINAL ARTICLES |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128183/ https://www.ncbi.nlm.nih.gov/pubmed/35279907 http://dx.doi.org/10.1111/cas.15329 |
work_keys_str_mv | AT hayashidatetsu feasibilitystudyoncollectingpatientreportedoutcomesfrombreastcancerpatientsusingthelineeprosystem AT nagayamaaiko feasibilitystudyoncollectingpatientreportedoutcomesfrombreastcancerpatientsusingthelineeprosystem AT sekitomoko feasibilitystudyoncollectingpatientreportedoutcomesfrombreastcancerpatientsusingthelineeprosystem AT takahashimaiko feasibilitystudyoncollectingpatientreportedoutcomesfrombreastcancerpatientsusingthelineeprosystem AT matsumotoakiko feasibilitystudyoncollectingpatientreportedoutcomesfrombreastcancerpatientsusingthelineeprosystem AT kubotaanna feasibilitystudyoncollectingpatientreportedoutcomesfrombreastcancerpatientsusingthelineeprosystem AT jinnohiromitsu feasibilitystudyoncollectingpatientreportedoutcomesfrombreastcancerpatientsusingthelineeprosystem AT miyatahiroaki feasibilitystudyoncollectingpatientreportedoutcomesfrombreastcancerpatientsusingthelineeprosystem AT kitagawayuko feasibilitystudyoncollectingpatientreportedoutcomesfrombreastcancerpatientsusingthelineeprosystem |